UBS analyst AJ Rice raised the firm’s price target on Universal Health (UHS) to $302 from $280 and keeps a Buy rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UHS:
- Universal Health price target raised to $233 from $200 at Morgan Stanley
- Universal Health: Balanced Outlook Amid MSPP Gains and Medicaid Challenges
- Universal Health price target raised to $253 from $227 at Guggenheim
- Universal Health Services Reports Strong Q3 2025 Results
- UHS Earnings Call: Mixed Outlook with Strong EPS Growth